Blue Jet Healthcare Limited is an India-based company, specializing in manufacturing integrated contrast media, artificial sweeteners and its salts, as well as niche pharmaceutical intermediaries and active pharmaceutical ingredients (APIs). The Company serves as a business-to-business (B2B) company. Its integrated contrast media intermediate product categories include x-ray contrast media intermediates and MRI contrast media intermediates. Its x-ray contrast media intermediates include non-ionic APIs and ionic APIs. It manufactures saccharin and supplies to healthcare, pharma, animal feed, food and beverages industries globally. The Company's offerings include insoluble saccharin, saccharin sodium and insoluble saccharin. Its advance pharmaceutical intermediates and API products include Vanillic Acid, Docusate Sodium and TosMIC. It offers end-to-end integrated solutions from process development to commercialization of NCEs, advance intermediates, APIs and building blocks.
BLUE JET HEALTHCARE LTD Financial Highlights
- Revenue: BLUE JET HEALTHCARE LTD reported revenue of ₹507.81 crore in FY21 vs ₹544.01 crore in FY20. It showed a decrease of 6.65% on a yearly basis.
- Operating Profit: BLUE JET HEALTHCARE LTD reported an operating profit of ₹184.66 crore in FY21 vs ₹194.13 crore in FY20. It showed a decrease of 4.88% on a year-on-year basis.
- Net Profit: BLUE JET HEALTHCARE LTD reported a net profit of ₹135.79 crore in FY21 vs ₹144.96 crore in FY20. It showed a decrease of 6.33% on a yearly basis.